General Information of This Metabolic Reaction (MR) (ID: MR005230)
Formula
SVG example
Oxidationn
Reactant Remoxipride Product Remoxipride Metabolite FLA 850
Reactant Info Product Info
Metabolic Type Oxidation - Oxidationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005227 Remoxipride Remoxipride Metabolite FLA 838 Oxidation - N-deethylation Remoxipride [1], [2]
MR005234 Remoxipride Remoxipride Metabolite FLA 853 Oxidation - N-dealkylation Remoxipride [1], [2]
MR005235 Remoxipride Unclear Unclear Remoxipride [3]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005233 Remoxipride Metabolite FLA 850 Remoxipride Metabolite NCL 118 Oxidation - N-deethylation Remoxipride [1], [2]
MR005231 Remoxipride Metabolite FLA 850 Remoxipride Metabolite NCM 001 Oxidation - Hydrolyzationn Remoxipride [1], [2]
References
1 Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors
2 The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function
3 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.